Easywell Biomedicals, Inc. 1799.TWO Stock
Easywell Biomedicals, Inc. Price Chart
Easywell Biomedicals, Inc. 1799.TWO Financial and Trading Overview
| Easywell Biomedicals, Inc. stock price | 66.5 TWD |
| Previous Close | 22.15 TWD |
| Open | 22.15 TWD |
| Bid | 22.1 TWD x 0 |
| Ask | 22.3 TWD x 0 |
| Day's Range | 22 - 22.4 TWD |
| 52 Week Range | 13.31 - 25.4 TWD |
| Volume | 81.32K TWD |
| Avg. Volume | 113.77K TWD |
| Market Cap | 2.53B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.25 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | July 26, 2010 |
| 1y Target Est | N/A |
1799.TWO Valuation Measures
| Enterprise Value | 2.52B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.4226422 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Easywell Biomedicals, Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 20.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 25.4 TWD |
| 52 Week Low | 13.31 TWD |
| 50-Day Moving Average | 20.8 TWD |
| 200-Day Moving Average | 16.99 TWD |
1799.TWO Share Statistics
| Avg. Volume (3 month) | 113.77K TWD |
| Avg. Daily Volume (10-Days) | 217.8K TWD |
| Shares Outstanding | 114.37M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 56.54% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 700:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 1.56 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -1.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 6.457 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Easywell Biomedicals, Inc.
| Country | Taiwan |
| State | N/A |
| City | Hsinchu City |
| Address | No.10, Yanfa 2nd Road |
| ZIP | 30076 |
| Phone | 886 3 666 9596 |
| Website | https://www.easywellbio.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Easywell Biomedicals, Inc., a biopharmaceutical and medical device company, develops and commercializes medical devices, drug substances, and pharmaceutical dosage forms in Taiwan and internationally. The company is developing TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; and TLX-011 for treatment of inflammatory lesions of rosacea. It also develops TWB-201 for Parkinson patch; TLX-501, an urinary medicine; and TLX-502, a pneumonia medicine. It also provides medical devices, including digital clinical thermometers, infrared ear thermometers, and transcutaneous electrical nerve stimulation products for pain relief. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.
Q&A For Easywell Biomedicals, Inc. Stock
What is a current 1799.TWO stock price?
Easywell Biomedicals, Inc. 1799.TWO stock price today per share is 66.5 TWD.
How to purchase Easywell Biomedicals, Inc. stock?
You can buy 1799.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Easywell Biomedicals, Inc.?
The stock symbol or ticker of Easywell Biomedicals, Inc. is 1799.TWO.
Which industry does the Easywell Biomedicals, Inc. company belong to?
The Easywell Biomedicals, Inc. industry is Medical Devices.
How many shares does Easywell Biomedicals, Inc. have in circulation?
The max supply of Easywell Biomedicals, Inc. shares is 121.87M.
What is Easywell Biomedicals, Inc. Price to Earnings Ratio (PE Ratio)?
Easywell Biomedicals, Inc. PE Ratio is now.
What was Easywell Biomedicals, Inc. earnings per share over the trailing 12 months (TTM)?
Easywell Biomedicals, Inc. EPS is -1.25 TWD over the trailing 12 months.
Which sector does the Easywell Biomedicals, Inc. company belong to?
The Easywell Biomedicals, Inc. sector is Healthcare.